IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-07472-8.html
   My bibliography  Save this article

Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis

Author

Listed:
  • Naiara Santana-Codina

    (Dana-Farber Cancer Institute)

  • Anjali A. Roeth

    (Dana-Farber Cancer Institute
    RWTH Aachen University Hospital)

  • Yi Zhang

    (Dana-Farber Cancer Institute)

  • Annan Yang

    (Dana-Farber Cancer Institute)

  • Oksana Mashadova

    (Weill Cornell Medicine)

  • John M. Asara

    (Beth Israel Deaconess Medical Center and Harvard Medical School)

  • Xiaoxu Wang

    (Dana-Farber Cancer Institute)

  • Roderick T. Bronson

    (Harvard Medical School)

  • Costas A. Lyssiotis

    (University of Michigan
    University of Michigan)

  • Haoqiang Ying

    (The University of Texas MD Anderson Cancer Center)

  • Alec C. Kimmelman

    (Dana-Farber Cancer Institute
    New York University School of Medicine)

Abstract

Oncogenic KRAS is the key driver of pancreatic ductal adenocarcinoma (PDAC). We previously described a role for KRAS in PDAC tumor maintenance through rewiring of cellular metabolism to support proliferation. Understanding the details of this metabolic reprogramming in human PDAC may provide novel therapeutic opportunities. Here we show that the dependence on oncogenic KRAS correlates with specific metabolic profiles that involve maintenance of nucleotide pools as key mediators of KRAS-dependence. KRAS promotes these effects by activating a MAPK-dependent signaling pathway leading to MYC upregulation and transcription of the non-oxidative pentose phosphate pathway (PPP) gene RPIA, which results in nucleotide biosynthesis. The use of MEK inhibitors recapitulates the KRAS-dependence pattern and the expected metabolic changes. Antagonizing the PPP or pyrimidine biosynthesis inhibits the growth of KRAS-resistant cells. Together, these data reveal differential metabolic rewiring between KRAS-resistant and sensitive cells, and demonstrate that targeting nucleotide metabolism can overcome resistance to KRAS/MEK inhibition.

Suggested Citation

  • Naiara Santana-Codina & Anjali A. Roeth & Yi Zhang & Annan Yang & Oksana Mashadova & John M. Asara & Xiaoxu Wang & Roderick T. Bronson & Costas A. Lyssiotis & Haoqiang Ying & Alec C. Kimmelman, 2018. "Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis," Nature Communications, Nature, vol. 9(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07472-8
    DOI: 10.1038/s41467-018-07472-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-07472-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-018-07472-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07472-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.